Patients' Willingness-to-pay of Endodontic Treatment
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03118323 |
Recruitment Status :
Active, not recruiting
First Posted : April 18, 2017
Last Update Posted : November 5, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Patient Preference | Other: Questionnaire |
Endodontic treatment of teeth with irreversibly damaged pulp aim at the long-term preservation of the affected tooth. If contraindications are present and / or a patient refuse endodontic treatment, the extraction of the affected tooth is often necessary. The resulting tooth gap might be closed by inserting a dental implant or by placing a fixed dental prosthesis.
Prior studies have shown that patients' decisions in alternative treatment options depend on a variety of factors. Studies on the willingness-to-pay (WTP) are used to compare the monetary value of different therapy procedures.
Study Type : | Observational |
Estimated Enrollment : | 200 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Patients' Willingness-to-pay of Endodontic Treatment |
Actual Study Start Date : | July 8, 2017 |
Estimated Primary Completion Date : | July 2021 |
Estimated Study Completion Date : | July 2021 |
Group/Cohort | Intervention/treatment |
---|---|
Patients in need of endodontic treatment
n = 200
|
Other: Questionnaire
Patients are given a questionnaire with items related to personality and their willingness-to-pay for different treatment options. |
- Completion of a questionnaire [ Time Frame: 10 minutes ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
- Department of Preventive Dentistry, Periodontology and Cariology, University Medical Center Göttingen, Germany
- Department of Operative and Preventive Dentistry, Charité - Universitätsmedizin Berlin, Germany
Participants are selected by consecutive patient sampling (total n = 200).
Inclusion Criteria:
- Patients who are in need of an primary root canal treatment and who are able to give written consent
Exclusion Criteria:
- Non-fulfillment of the inclusion criteria
- Lack of capacity to consent
- No German language skills in written and spoken language
- Age <18 years

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03118323
Germany | |
University Medical Center Göttingen, Dept. of Preventive Dentistry, Periodontology and Cariology | |
Göttingen, Lower Saxony, Germany, 37075 | |
Charité - Universitätsmedizin Berlin, Dept. of Operative and Preventive Dentistry | |
Berlin, Germany, 14197 |
Principal Investigator: | Annette Wiegand, Prof. Dr. med. dent. | Dept. of Prev. Dentistry, Periodontology and Cariology, University Medical Center Göttingen, Germany |
Responsible Party: | Philipp Kanzow, Dr. med. dent., Dr. rer. medic., Dr. med. dent., University Medical Center Goettingen |
ClinicalTrials.gov Identifier: | NCT03118323 |
Other Study ID Numbers: |
WTP-Endodontic |
First Posted: | April 18, 2017 Key Record Dates |
Last Update Posted: | November 5, 2020 |
Last Verified: | November 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
willingness topay WTP health economic preference-based measures |